These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6149594)

  • 1. The staircase test in mice: a simple and efficient procedure for primary screening of anxiolytic agents.
    Simiand J; Keane PE; Morre M
    Psychopharmacology (Berl); 1984; 84(1):48-53. PubMed ID: 6149594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The staircase test: some evidence of nonspecificity for anxiolytics.
    Pollard GT; Howard JL
    Psychopharmacology (Berl); 1986; 89(1):14-9. PubMed ID: 2874582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiety-like and exploratory behaviors of isolation-reared mice in the staircase test.
    Ago Y; Takahashi K; Nakamura S; Hashimoto H; Baba A; Matsuda T
    J Pharmacol Sci; 2007 Jun; 104(2):153-8. PubMed ID: 17538228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing benzodiazepines using the staircase test in mice.
    Stéru L; Thierry B; Chermat R; Millet B; Simon P; Porsolt RD
    Psychopharmacology (Berl); 1987; 92(1):106-9. PubMed ID: 2885879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines.
    Crawley JN
    Pharmacol Biochem Behav; 1981 Nov; 15(5):695-9. PubMed ID: 6118883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A combined marble burying-locomotor activity test in mice: a practical screening test with sensitivity to different classes of anxiolytics and antidepressants.
    Nicolas LB; Kolb Y; Prinssen EP
    Eur J Pharmacol; 2006 Oct; 547(1-3):106-15. PubMed ID: 16934246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small platform stress increases exploratory activity of mice in staircase test.
    Pokk P; Väli M
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Oct; 25(7):1435-44. PubMed ID: 11513357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gerbil elevated plus-maze I: behavioral characterization and pharmacological validation.
    Varty GB; Morgan CA; Cohen-Williams ME; Coffin VL; Carey GJ
    Neuropsychopharmacology; 2002 Sep; 27(3):357-70. PubMed ID: 12225693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacology of VA21B7: an atypical 5-HT3 receptor antagonist with anxiolytic-like properties in animal models.
    Artaiz I; Romero G; Zazpe A; Monge A; Calderó JM; Roca J; Lasheras B; Del Río J
    Psychopharmacology (Berl); 1995 Jan; 117(2):137-48. PubMed ID: 7753959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditioned defensive burying as a model for identifying anxiolytics.
    Craft RM; Howard JL; Pollard GT
    Pharmacol Biochem Behav; 1988 Jul; 30(3):775-80. PubMed ID: 2905472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new sensitive method which unlike the Vogel test detects the anxiolytic effect of tofisopam.
    Miklya I; Knoll J
    Pol J Pharmacol Pharm; 1988; 40(6):561-72. PubMed ID: 2908362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychopharmacological profile in rodents of SR 57746A, a new, potent 5-HT1A receptor agonist.
    Simiand J; Keane PE; Barnouin MC; Keane M; Soubrié P; Le Fur G
    Fundam Clin Pharmacol; 1993; 7(8):413-27. PubMed ID: 7904976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of benzodiazepines and amphetamine on exploratory behaviour in weanling rats: an animal model for anxiolytic activity.
    Salt JS; Taberner PV
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):163-9. PubMed ID: 6145184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A fully automated light/dark apparatus useful for comparing anxiolytic agents.
    Young R; Johnson DN
    Pharmacol Biochem Behav; 1991 Dec; 40(4):739-43. PubMed ID: 1687762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The benzodiazepine diazepam demonstrates the usefulness of Syrian hamsters as a model for anxiety testing: evaluation of other classes of anxiolytics in comparison to diazepam.
    Gannon RL; Lungwitz E; Batista N; Hester I; Huntley C; Peacock A; Delagrange P; Millan MJ
    Behav Brain Res; 2011 Mar; 218(1):8-14. PubMed ID: 21094664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioural pharmacology of benzodiazepines.
    File SE
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):19-31. PubMed ID: 6145185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prior test experience compromises the anxiolytic efficacy of chlordiazepoxide in the mouse light/dark exploration test.
    Holmes A; Iles JP; Mayell SJ; Rodgers RJ
    Behav Brain Res; 2001 Aug; 122(2):159-67. PubMed ID: 11334646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiolytic effects of valproate and diazepam in mice are differentially sensitive to picrotoxin antagonism.
    Dalvi A; Rodgers RJ
    Pharmacol Biochem Behav; 2001 Jan; 68(1):23-32. PubMed ID: 11274704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the neuroactive steroid alpha-THDOC on staircase test behavior in mice.
    Pick CG; Peter Y; Terkel J; Gavish M; Weizman R
    Psychopharmacology (Berl); 1996 Nov; 128(1):61-6. PubMed ID: 8944407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioural effects of the benzodiazepine receptor partial agonist RO 16-6028 in mice.
    Belzung C; Misslin R; Vogel E
    Psychopharmacology (Berl); 1989; 97(3):388-91. PubMed ID: 2566186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.